Difficulties of Managing Submassive and Massive Pulmonary Embolism in the Era of COVID-19

Autor:	Amir Darki, Alexandru Marginean, Dalila Masic, Yevgeniy Brailovsky, Jawed Fareed
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	0301 basic medicine medicine.medical_specialty Coronavirus disease 2019 (COVID-19) viruses 030105 genetics & heredity right ventricle medicine.disease_cause Article 03 medical and health sciences 0302 clinical medicine Venous thromboembolic disease Internal medicine Medicine Diseases of the circulatory (Cardiovascular) system DIC disseminated intravascular coagulation UFH unfractionated heparin Thrombus Respiratory system anticoagulation ARDS acute respiratory distress syndrome Coronavirus RV/LV right ventricular to left ventricular diameter ratio business.industry SBP systolic blood pressure virus diseases computed tomography PUI patient under investigation medicine.disease Thrombosis Pulmonary embolism CDT catheter directed thrombolysis Increased risk TTE transthoracic echocardiography pulmonary circulation thrombus RC666-701 PE pulmonary embolism Cardiology RV right ventricular Cardiology and Cardiovascular Medicine business 030217 neurology & neurosurgery
Zdroj:	JACC: Case Reports, Vol 2, Iss 9, Pp 1383-1387 (2020) JACC: Case Reports Jacc. Case Reports
ISSN:	2666-0849
Popis:	Acute pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolic disease. SARS-COV2, a novel coronavirus that causes COVID-19, has been associated with increased risk of thrombosis. We describe the therapeutic challenges of three patients presenting with PE and suspected or confirmed COVID-19. Graphical abstract
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c6a362398e74798c99f2b6211af6e0 http://www.sciencedirect.com/science/article/pii/S2666084920304800 Zobrazit plný text záznamu